Results 311 to 320 of about 157,892 (348)

Electrophysiology of atropine

Cardiovascular Research, 1975
The effect of atropine on the refractory periods of the human atrium, A-V node, and His-Purkinje system was studied. The A-V node in man appears more sensitive to atropine than the atria as evidenced by a reduction in the effective and functional refractory periods of the A-V node without alteration of atrial conduction.
J K, Bissett, N D, de Soyza, J J, Kane, M L, Murphy   +3 more
openaire   +2 more sources

One‐year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial

Ophthalmic & physiological optics, 2020
To report the 1‐year results of an investigation into whether there is an additive effect between 0.01% atropine and orthokeratology (ortho‐k), in a single‐masked, two‐arm, randomised controlled trial: Combined Atropine with Orthokeratology (AOK) for ...
Qi Tan, Alex L. K. Ng, Bonnie N. K. Choy, G. P. Cheng, Victor C. P. Woo, P. Cho   +5 more
semanticscholar   +1 more source

Comparisons of atropine versus cyclopentolate cycloplegia in myopic children.

Clinical and experimental optometry, 2020
CLINICAL RELEVANCE In clinical practice, 1% atropine and 1% cyclopentolate are used as cycloplegia agents to diagnose refractive error. The influence of 1% atropine on ocular biometry is obscure, and the impact of 1% cyclopentolate remains controversial.
Luyao Ye, Shan-shan Li, Ya Shi, Yao Yin, Jiangnan He, Jianfeng Zhu, Xun Xu   +6 more
semanticscholar   +1 more source

The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.

Eye & contact lens, 2020
OBJECTIVES Previous studies have found that atropine can slow axial elongation and control the progression of myopia. Some ongoing trials have applied atropine combined with orthokeratology for myopia control, but few studies explored the effect of the ...
C. Gao, S. Wan, Yuting Zhang, Jing Han
semanticscholar   +1 more source

Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children — a prospective, randomized, double-masked, and crossover trial

European Journal of Pediatrics, 2023
Wei-qun Wang, Feng-yan Zhang, Shi-Zhi Yu, Nan Ma, Congcong Huang, Ming Wang, Li Wei, Junjie Zhang, Aicun Fu   +8 more
semanticscholar   +1 more source

Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study

Japanese Journal of Ophthalmology, 2021
Osamu Hieda, T. Hiraoka, T. Fujikado, S. Ishiko, S. Hasebe, H. Torii, Hiroshi Takahashi, Yo Nakamura, C. Sotozono, T. Oshika, T. Morimoto, K. Nishida, Noriko Nishikawa, Y. Song, Tomoki Tokutake, Yasuyo Nishi, Yuta Shigeno, T. Kurihara, K. Negishi, K. Tsubota, M. Ono, T. Nakai, D. Tan, Shiro Tanaka, S. Kinoshita   +24 more
semanticscholar   +1 more source

A Review of Myopia Control with Atropine

Journal of Ocular Pharmacology and Therapeutics, 2018
Myopia is a global public health issue with a worldwide prevalence of ∼30% and is estimated to rise to 50% by 2050. In addition to the burden associated with routine management of the condition, high myopia predisposes the eye to sight-threatening ...
H. Tran, Y. H. Tran, T. Tran, M. Jong, M. Coroneo, P. Sankaridurg   +5 more
semanticscholar   +1 more source

Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study.

Ophthalmology (Rochester, Minn.), 2021
F. Li, Yuzhou Zhang, X. Zhang, B. Yip, S. Tang, K. Kam, A. Young, L. J. Chen, C. Tham, C. Pang, J. Yam   +10 more
semanticscholar   +1 more source

The Parasympathomimetic Activity of Atropine and Atropine Methylbromide

Anesthesiology, 1968
C A, Kottmeier, J S, Gravenstein
openaire   +2 more sources

Atropine

Reactions Weekly, 2022
  +5 more sources